Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 4, 2026 · Other material event · Financial statements
Kairos Pharma, LTD.
8
Other material event
Jun 4, 2026
Public companies file this within four business days when something important happens that investors should know about before the next quarterly report.
Kairos Pharma, LTD. filed this to release information to investors under Regulation FD — usually a press release, conference presentation, or other event the company considers important. 1 Kairos Pharma Recaps Important Acquisitions and Details Plans for the Balance of 2026 in Letter to Shareholders LOS ANGELES, June 4, 2026 – (Business Wire) – Kairos Pharma Ltd . (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, provides a mid-year update for 2026 and a look ahead to the…
Kairos Pharma, LTD.
8-K
1962011
Jun 4, 2026
0001493152-26-027200
